---
title: "Orchestra BioMed secures additional capital from funding partners"
date: "2025-08-05T15:30:01.000Z"
publishedDate: "5 août 2025"
summary: "Orchestra BioMed has secured US$70 million in new capital from Ligand Pharmaceuticals and Medtronic to advance its late-stage partnered cardiology programmes—arterioventricular interval modulation (AVIM) therapy and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB). Simultaneously, Orchestra BioMed and Medtronic, which have an existing strategic collaboration for AVIM therapy for the treatment of uncontrolled hypertension in pacemaker-indicated [&#8230;] The post Orchestra BioMed secures additional capital from funding partners appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/orchestra-biomed-secures-additional-capital-from-funding-partners/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-08-05-orchestra-biomed-secures-additional-capital-from-funding-partners"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2019/06/OrchestraBiomedVirtueSEB-766x512.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/orchestra-biomed-secures-additional-capital-from-funding-partners/"
---

![Orchestra BioMed secures additional capital from funding partners](https://cardiovascularnews.com/wp-content/uploads/sites/14/2019/06/OrchestraBiomedVirtueSEB-766x512.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/orchestra-biomed-secures-additional-capital-from-funding-partners/*

## L’essentiel

Orchestra BioMed has secured US$70 million in new capital from Ligand Pharmaceuticals and Medtronic to advance its late-stage partnered cardiology programmes—arterioventricular interval modulation (AVIM) therapy and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB). Simultaneously, Orchestra BioMed and Medtronic, which have an existing strategic collaboration for AVIM therapy for the treatment of uncontrolled hypertension in pacemaker-indicated [&#8230;] The post Orchestra BioMed secures additional capital from funding partners appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/orchestra-biomed-secures-additional-capital-from-funding-partners/
